Cargando…
Immunological response in mice bearing LM3 breast tumor undergoing Pulchellin treatment
BACKGROUND: Ribosome-inactivating proteins (RIP) have been studied in the search for toxins that could be used as immunotoxins for cancer treatment. Pulchellin, a type 2 RIP, is suggested to induce immune responses that have a role in controlling cancer. METHODS: The percentage of dendritic cells an...
Autores principales: | de Matos, Djamile Cordeiro, de Ribeiro, Lívia Carolina Abreu, Tansini, Aline, Ferreira, Lucas Souza, Placeres, Marisa Campos Polesi, Colombo, Lucas Luis, Carlos, Iracilda Zeppone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479043/ https://www.ncbi.nlm.nih.gov/pubmed/22827934 http://dx.doi.org/10.1186/1472-6882-12-107 |
Ejemplares similares
-
Repeated Exposition to Mercury (II) Chloride Enhances Susceptibility to S. schenckii sensu stricto Infection in Mice
por: Batista-Duharte, Alexander, et al.
Publicado: (2018) -
Selective cytotoxicity of a novel immunotoxin based on pulchellin A chain for cells expressing HIV envelope
por: Sadraeian, Mohammad, et al.
Publicado: (2017) -
Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.
por: Double, J. A., et al.
Publicado: (1986) -
Sporothrix schenckii Cell Wall Proteins-Stimulated BMDCs Are Able to Induce a Th1-Prone Cytokine Profile In Vitro
por: Quinello, Camila, et al.
Publicado: (2018) -
Expression of murine Lm-1 locus. Lm-1 determinants on lymphocytes and macrophages, and effects of Lm-1 incompatibility on bone marrow grafts
Publicado: (1985)